ANNE HALL: Open Payments
NPI 1194457937 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 35 payments from 16 companies in 2025. Trend: 2023 $917 · 2024 $1,054 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $249 |
| PFIZER INC. | 6 | $120 |
| Lilly USA, LLC | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Amgen Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Phadia US Inc. | 1 | $24 |
Products named: VRAYLAR, UBRELVY, NURTEC ODT, QULIPTA, KISUNLA, Kerendia, GARDASIL 9, SHINGRIX.
Industry payments across CO — which companies pay providers there.
